Page last updated: 2024-08-25

clarithromycin and Empyema, Pleural, Tuberculous

clarithromycin has been researched along with Empyema, Pleural, Tuberculous in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cheng, HH; Cheng, KC; Huang, HC; Shieh, CC; Yu, WL1

Other Studies

1 other study(ies) available for clarithromycin and Empyema, Pleural, Tuberculous

ArticleYear
Unusual mixed infection of thoracic empyema caused by Mycobacteria tuberculosis, nontuberculosis mycobacteria and Nocardia asteroides in a woman with systemic lupus erythematosus.
    The Journal of infection, 2007, Volume: 54, Issue:1

    Topics: Antitubercular Agents; Clarithromycin; Drug Therapy, Combination; Empyema, Pleural; Empyema, Tuberculous; Female; Humans; Immunocompromised Host; Immunoglobulins, Intravenous; Lupus Erythematosus, Systemic; Middle Aged; Mycobacterium; Nocardia asteroides; Taiwan; Trimethoprim, Sulfamethoxazole Drug Combination

2007